期刊文献+

原位移植体内连续筛选法建立人胃恶性淋巴瘤裸小鼠高转移模型系统 被引量:3

Highly metastatic nude mouse model of human primary gastric lymphoma constructed by surgical orthotopic transplantation and in vivo continuous screening method
原文传递
导出
摘要 目的建立侵袭和转移潜能不同的人胃恶性淋巴瘤裸鼠原位移植高转移模型系统。方法将外科手术切除的人原发性胃恶性淋巴瘤原发灶和肝转移灶新鲜瘤组织块分别植入裸小鼠胃壁黏膜下层内,通过鼠间连续原位传代技术筛选高转移和特异器官转移瘤株。观察原位移植的成瘤率、移植瘤的侵袭、转移特性,并进行形态学(光镜、电镜、免疫组织化学)、染色体核型和流式细胞分析。结果人胃恶性淋巴瘤原发灶和肝转移灶新鲜组织均移植成功,建立了两株转移生物学特性不同的人胃(肝转移灶)恶性淋巴瘤裸鼠原位移植肝转移模型(HGBL-0304)和人胃(原发灶)恶性淋巴瘤裸鼠原位移植高转移模型(HGBL-0305)。移植瘤组织病理学为胃弥漫大B细胞淋巴瘤。两株模型分别传至45代,共移植裸鼠419只,其中肿瘤移植生长率和液氮冻存复苏成活率均为100%。在转移时间、器官转移率、肝转移程度和宿主生存期上两株模型差异有统计学意义。HGBL-0304和HGBL-0305模型肝转移率为100%和69.5%,脾转移率为94.3%和55.6%,淋巴结转移率为62.6%和45.7%,腹腔种植转移率为43.5%和30.5%;肝、脾、淋巴结和腹腔种植转移出现时间分别为移植后2周和5周,3周和6周,2周和3周,3周和6周。HGBL-304和HGBL-0305模型肝转移分别以弥漫累及肝左右叶为主和肝右叶累及为主。HGBL-0304和HGBL-0305模型荷瘤鼠平均生存期分别为54.3d和106.9d。结论外科原位移植体内筛选法是一种建立人恶性淋巴瘤裸鼠高转移模型和特异器官转移模型的有效方法。HGBL-0304和HGBL-0305模型是首次成功建立的来自同一瘤源的两株侵袭和转移潜能不同的人胃恶性淋巴瘤裸鼠原位移植肝转移模型和高转移模型。 Objective To develop a series of high metastatic models of human gastric malignant lymphoma in nude mice by orthotopic transplantation. Methods Two histologically intact primary and hepatic metastatic fragments derived from surgical specimen of a patient with primary gastric lymphoma were implanted into the submucosa of stomach in nude mice. Highly metastatic and specific organ metastatic models were screened by selective orthotopic passage in nude mice. Transplantability, invasion, metastasis, morphological characteristics (light microscopy, electron microscopy and immunohistochemistry) , karyotypic analysis and DNA content of orthotopically transplanted tumors were studied. Results Primary and hepatic metastatic fragments of primary gastric lymphoma were successfully transplanted in nude mice. Two nude mouse models of human primary gastric lymphoma, termed HGBL-0304 (hepatic metastasis model ) and HGBL-0305 (high metastasis model ), were developed, exhibiting different metastasis biology. Histopathology of transplanted tumors showed primary gastric diffuse large B cell lymphoma. Two models have been maintained for 45 generations by orthotopic passage in nude mice. A total of 419 nude mice were used for transplantation. The growth rate and resuscitation rate of liquid nitrogen cryopreservation oftransplanted tumors were both 100%. Significant difference in metastasis biology was exhibited in four aspects of metastasis time, organ metastatic rate, the extent of hepatic metastasis and survival of cancerbearing mice. The metastatic rates of liver, spleen, lymph nodes and peritoneal seeding in HGBL-0304 and HGBL-0305 models were 100% and 69. 5%, 94.3% and 55.6%, 62. 6% and 45. 7%, and 43.5% and 30. 5%. The onset time for metastases of liver, spleen, lymph nodes and peritoneal seeding was 2 w and 5 w, 3 w and 6 w, 2 w and 3 w, 3 w and 6 w respectively. The extent of hepatic metastasis in HGBL-0304 and HGBL-0305 models displayed diffuse involvement of the whole liver and mainly right lobe invasion of liver respectively. The mean survival time of HGBL-030d and HGBL-0305 models was 54. 3d and 106. 9 d respectively. Conclusion Surgical orthotopic implantation combined with in vivo selective passage screening is an effective method for establishing highly metastatic and specific organ metastatic models of human malignant lymphoma in nude mice. The study is the first time to establish hepatic metastasis and high metastasis nude mouse models of human primary gastric lymphoma with the same original patient and different potentials of invasion and metastasis.
出处 《中华医学杂志》 CAS CSCD 北大核心 2010年第6期413-417,共5页 National Medical Journal of China
基金 国家重点科技攻关计划基金(96A230603) 辽宁省自然科学基金(20042153)
关键词 胃肿瘤 淋巴瘤 肿瘤移植 肿瘤转移 Stomach neoplasms Lymphoma Neoplasm transplantation Neoplasm metastasis
  • 相关文献

参考文献9

  • 1Bibby MC. Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages. Eur J Cancer, 2004, 40 : 852-857.
  • 2Hoffman RM. Orthotopic metastatic (MetaMouse) models for discovery and development of novel chemotherapy. Methods Mol Med, 2005, 111:297-322.
  • 3Muller AM, lhorst G, Mertelsmann R, et al. Epidemiology of non-Hodgkin' s lymphoma ( NHL ) : trends, geographic distribution, and etiology. Ann Hematol, 2005, 84 : 1-12.
  • 4Krugmann J, Gschwendtner A,Mairinger T, et al. DNA ploidy in gastrointestinal B-cell lymphomas. An image analysis study of 43 cases. Anal 0uant Cvtol Histol, 2003, 25:31-38.
  • 5刘秋珍,脱朝伟,张宁,杨波,王承利.人原发性结肠恶性淋巴瘤裸小鼠原位移植肝转移模型的建立[J].中华胃肠外科杂志,2006,9(4):323-327. 被引量:4
  • 6Jaffe ES, Harris NL, Stein H, et al. Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. Blood, 2008, 112 : 4384-4399.
  • 7Abramson J, Shipp MA. Advances in the biology and therapy of diffuse large B-cell lymphoma-moving towards a molecularly targeted approach. Blood, 2005, 106 : 1164-1174.
  • 8Koniaris LG, Drugas G, Katzman PJ, et al. Management of gastrointestinal lymphoma. J Am Coil Surg, 2003,197 : 127-141.
  • 9Moiler MB, Pedersen NT, Chfistensen BE. Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation--a population-based study of 1575 cases. Br J Haematol, 2004, 124 : 151-159.

二级参考文献11

  • 1刘秋珍,脱朝伟,张宁,杨波,王明耀.人小肠原发性恶性淋巴瘤裸小鼠原位和皮下移植高转移模型的建立[J].中华胃肠外科杂志,2004,7(4):308-311. 被引量:5
  • 2Vilanueva-Saenz E,Alvarez-Tostado Fernandez JF,Martinez Hernandez-magro P,et al.Colonic primary lymphoma.Rev Gastroenterol Mex,2002,67:28-33.
  • 3Kohno S,Ohshima K,Yoneda S,et al.Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification.Histopathology,2003,43:135-143.
  • 4Iarumov N,Terziev I,Gachev N,et al.Surgical treatment of complicated gastrointestinal forms of non-Hodgkin lymphomas.Khirurgiia(Sofiia),2002,58:7-9.
  • 5Krugmann J,Gschwendtner A,Mairinger T,et al.DNA ploidy in gastrointestinal b-cell lymphomas:an image analysis study of 43 cases.Analyt Quant Cytol Histol,2003,25:31-38.
  • 6Baschinsky DY,Weidner N,Backer PB,et al.Primary hepatic anaplastic Iargercell lymphoma of T-cell phenotype in acquired immumodeficiency syndrome:a report of an autopsy case and review of the literature.Am J Castroenterol,2001,96:227-232.
  • 7Luzzi KJ,MacDonald IC,Schmidt EC,et al.Multistep nature of metastatic inefficiency:dormancy of solitary cells after successful extravasation and limited survival of early micrometastases.Am J Pathol,1998,153:865-873.
  • 8Cowan RA,Jones M,Harris M,et al.Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.Br J Cancer,1989,59:276-282.
  • 9Leichman CG,Jacobson JR,Modiano M,et al.Hepatic chemoembolization combined with systemic infusion of 5-fluorouracil and bolus leucovorin for patients with metastatic colorectal carcinoma:A Southwest Oncology Group pilot trial.Cancer,1999,86:7757-7781.
  • 10Leonidas GK,George D,Philip JK,et al.Mannagement of gastroitestinal lymphoma.J Am Coll Surg,2003,197:127-131.

共引文献3

同被引文献16

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部